Perrigo Company PLC
NYSE:PRGO

Watchlist Manager
Perrigo Company PLC Logo
Perrigo Company PLC
NYSE:PRGO
Watchlist
Price: 24.245 USD 0.81%
Market Cap: 3.3B USD

Perrigo Company PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Perrigo Company PLC
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Perrigo Company PLC
NYSE:PRGO
Revenue
$4.4B
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
1%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Revenue
$4B
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
14%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Revenue
$138.2m
CAGR 3-Years
N/A
CAGR 5-Years
15%
CAGR 10-Years
27%
Cosmo Pharmaceuticals NV
SIX:COPN
Revenue
€189.3m
CAGR 3-Years
44%
CAGR 5-Years
30%
CAGR 10-Years
10%
Ovoca Bio PLC
LSE:OVB
Revenue
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Perrigo Company PLC
Revenue Breakdown

Breakdown by Geography
Perrigo Company PLC

Total Revenue: 4.7B USD
100%
United States: 2.9B USD
62.7%
Europe: 1.6B USD
34.9%
All Other Countries: 116.3m USD
2.5%
Ireland: 40.8m USD
0.9%
Show More

Breakdown by Segments
Perrigo Company PLC

Total Revenue: 4.7B USD
100%
Csca: 3B USD
63.6%
Csci: 1.7B USD
36.4%

Perrigo Company PLC
Glance View

Market Cap
3.3B USD
Industry
Pharmaceuticals

Perrigo Company PLC, a stalwart in the pharmaceutical and healthcare sectors, has carved a niche by specializing in over-the-counter (OTC) health and wellness products. This Dublin-based company traces its origins back to 1887, in Allegan, Michigan, where it began as a modest packager of home remedies. Over the decades, Perrigo has evolved into a global powerhouse that provides affordable and quality healthcare products, distributing them across various markets around the world. Its strategy hinges on delivering effective OTC solutions and a wide array of consumer self-care products, making it a familiar presence in households seeking reliable alternatives to more expensive brand-name pharmaceuticals. Perrigo's business model is centered on offering value to both consumers and retailers. By producing generic versions of well-known drugs, it captures a significant share of the market driven by cost-conscious customers. This approach also involves collaborating with retail giants to supply their private label OTC medications, a mutually beneficial arrangement that allows retailers to offer lower-cost alternatives under their own brands while maintaining healthy margins. Beyond just OTC medications, Perrigo has expanded its offerings to include nutritional products and topical solutions, further diversifying its portfolio and revenue streams. The company's consistent investment in innovation and keen attention to regulatory compliance underscore its commitment to quality and safety, attributes that resonate well in an industry guided by trust and efficacy.

PRGO Intrinsic Value
65.187 USD
Undervaluation 63%
Intrinsic Value
Price

See Also

What is Perrigo Company PLC's Revenue?
Revenue
4.4B USD

Based on the financial report for Sep 28, 2024, Perrigo Company PLC's Revenue amounts to 4.4B USD.

What is Perrigo Company PLC's Revenue growth rate?
Revenue CAGR 10Y
1%

Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for Perrigo Company PLC have been 2% over the past three years , -1% over the past five years , and 1% over the past ten years .

Back to Top